Which blood test indicator can reveal hemophilia?
Hemophilia can usually be identified through coagulation screening tests, particularly the four-item coagulation panel and quantitative clotting factor assays.
Hemophilia is a coagulation disorder caused by a deficiency of clotting factors in the blood. The condition can typically be confirmed through routine blood tests. A complete blood count (CBC) showing normal platelet levels helps rule out thrombocytopenia as the cause. If the four-item coagulation panel reveals a significantly prolonged activated partial thromboplastin time (aPTT) with other parameters normal, congenital clotting factor deficiency should be suspected. Further testing for intrinsic clotting factor levels is required to confirm a diagnosis of hemophilia. However, if both prothrombin time (PT) and aPTT are prolonged—especially with only mild prolongation of aPTT—the cause may instead be an acquired clotting factor deficiency.
After diagnosis, individuals with hemophilia should avoid injuries that could lead to bleeding or hemorrhage. In cases of bleeding, treatment should be administered according to disease severity under medical supervision.